Literature DB >> 20415654

Vascular microRNAs.

Angelika Bonauer1, Reinier A Boon, Stefanie Dimmeler.   

Abstract

MicroRNAs are endogenously expressed small non-coding RNAs that regulate gene expression on the posttranscriptional level. During the last years microRNAs have emerged as key regulators of several physiological and pathophysiological processes in the vascular wall. Endothelial cell functions and angiogenesis are critically regulated by microRNAs such as miR-126 and the miR-17-92 cluster in vitro and in vivo. Tumor angiogenesis is additionally controlled by miR-296 and miR-378. MicroRNAs also regulate smooth muscle cell phenotypes and control neointima formation and atherosclerosis. In this respect, miR-143 and miR-145 have been shown to play a crucial role. In this review, we summarize the role of microRNAs and their target genes in endothelial and smooth muscle cells and discuss their applicability as drug targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415654     DOI: 10.2174/138945010791591313

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  58 in total

1.  MicroRNA profiling of antler stem cells in potentiated and dormant states and their potential roles in antler regeneration.

Authors:  Hengxing Ba; Datao Wang; Chunyi Li
Journal:  Mol Genet Genomics       Date:  2016-01-06       Impact factor: 3.291

2.  Absence of mutation in miR-34a gene in a Chinese longevity population.

Authors:  Huan Wu; Yong-Han He; Tian-Rui Xu; Qing-Peng Kong
Journal:  Dongwuxue Yanjiu       Date:  2015-03-18

Review 3.  30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.

Authors:  Jennifer J DuPont; Iris Z Jaffe
Journal:  J Endocrinol       Date:  2017-07       Impact factor: 4.286

4.  Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children.

Authors:  Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Ahamed A Khalyfa; David Gozal
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

Review 5.  Tumor angiogenesis: molecular pathways and therapeutic targets.

Authors:  Sara M Weis; David A Cheresh
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 6.  Therapeutic use of microRNAs in myocardial diseases.

Authors:  Michael V G Latronico; Gianlugi Condorelli
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 7.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

8.  Cloning and characterization of Bubaline mammary miRNAs: An in silico approach.

Authors:  Krishnadeo Ankush Khade; Manjit Panigrahi; Sheikh Firdous Ahmad; Anuj Chauhan; Pushpendra Kumar; Bharat Bhushan
Journal:  Mol Biol Rep       Date:  2019-02-20       Impact factor: 2.316

9.  Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.

Authors:  Tamia A Harris; Munekazu Yamakuchi; Maiko Kondo; Peter Oettgen; Charles J Lowenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-29       Impact factor: 8.311

10.  MicroRNA-26a regulates pathological and physiological angiogenesis by targeting BMP/SMAD1 signaling.

Authors:  Basak Icli; A K M Wara; Javid Moslehi; Xinghui Sun; Eva Plovie; Meghan Cahill; Julio F Marchini; Andrew Schissler; Robert F Padera; Jianru Shi; Hui-Wen Cheng; Srilatha Raghuram; Zoltan Arany; Ronglih Liao; Kevin Croce; Calum MacRae; Mark W Feinberg
Journal:  Circ Res       Date:  2013-09-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.